Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  The shares of common stock, par value $0.000001 per share (the "Common Stock") of Instil Bio, Inc. (the "Issuer") are held of record by Vivo Capital Fund IX, L.P. as of June 30, 2025. Vivo Capital IX, LLC is the general partner of Vivo Capital Fund IX, L.P. Based on 6,559,927 shares of Common Stock issued and outstanding as of May 9, 2025, as disclosed in the Issuer's Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission (the "SEC") on May 13, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The shares of Common Stock of the Issuer are held of record by Vivo Capital Fund IX, L.P. as of June 30, 2025. Vivo Capital IX, LLC is the general partner of Vivo Capital Fund IX, L.P. Based on 6,559,927 shares of Common Stock issued and outstanding as of May 9, 2025, as disclosed in the Issuer's Quarterly Report on Form 10-Q, filed with the SEC on May 13, 2025.


SCHEDULE 13G



 
Vivo Capital IX, LLC
 
Signature:/s/ Frank Kung
Name/Title:Frank Kung/Managing Member
Date:08/12/2025
 
Vivo Capital Fund IX, L.P.
 
Signature:/s/ Frank Kung
Name/Title:Frank Kung/Managing Member
Date:08/12/2025